Divergent expression of CD133 in different studies: The need for a consensus panel?

International Journal of Cancer

Volumn 128, Issue 9, 2011, Pages 2247-2249

  Sgambato, Alessandro ^a   Errico, Federica ^a   Caredda, Emanuele ^a   Puglisi, Maria A ^a   Cittadini, Achille ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

CANCER CELL CULTURE; CANCER STEM CELL; CELL STRAIN CACO 2; CELL STRAIN HCT116; CELL STRAIN HT29; COLON CANCER; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

ANTIGENS, CD; BLOTTING, WESTERN; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL SEPARATION; CONSENSUS; FLOW CYTOMETRY; GLYCOPROTEINS; HCT116 CELLS; HT29 CELLS; HUMANS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 79952456932     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25551     Document Type: Letter

References (10)

1. Gemei M, Mirabelli P, Di Noto R, Fortunato G, Vecchio L. Divergent expression of CD133 in different studies on HCT-116 cell line. Int J Cancer, in press.
2. Elsaba T, Martinez-Pomares L, Robins A, Crook S, Seth R, Jackson D, McCart A, Silver A, Tomlinson I, Ilyas M. The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer. PLoS One 2010;5:e10714.
3. Dallas N, Xia L, Fan F, Gray M, Gaur P, van Buren G, II, Samuel S, Kim M, Lim S, Ellis L. Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 2009;69:1951-7.
4. Oh S, Kang K, Youn H, Kim Y-H, Lee H-Y, Chung J-K, Lee M, Lee D. In vivo molecular imaging of cancer stem cells in mice with xenografted colon cancer. J Nucl Med Meet Abstr 2010;51:1119.
5. Kemper K, Sprick M, de Bree M, Scopelliti A, Vermeulen L, Hoek M, Zeilstra J, Pals ST, Mehmet H, Stassi G, Medema J. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res 2010;70:719-29.
6. Sgambato A, Puglisi M, Errico F, Rafanelli F, Boninsegna A, Rettino A, Genovese G, Coco C, Gasbarrini A, Cittadini A. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection. J Cell Physiol 2010;224:234-41.
7. Mariotti E, Gemei M, Mirabelli P, D'Alessio F, Di Noto R, Fortunato G, Del Vecchio L. The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection. BMC Cancer 2010;10:120.
8. Jaksch M, Múnera J, Bajpai R, Terskikh A, Oshima R. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res 2008;68: 7882-6.
9. Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y, Tamura D, Aomatsu K, Tamura T, Yamada Y, Saijo N, Nishio K. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells. Cancer Res 2009;69:7160-4.
10. Yi J, Tsai H, Glöckner S, Lin S, Ohm J, Easwaran H, James C, Costello J, Riggins G, Eberhart C, Laterra J, Vescovi A, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008;68:8094-103.